Neuroscience Therapeutics companies

A venture fund investing in early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies globally.

A venture capital firm uniquely dedicated to the frontier of neuroscience.

Invested in breaking ‍through paralysis.

Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.

A £250m specialist venture capital fund that invests in, and creates, new biotech companies to deliver high impact therapeutics for age-related dementias.

A CHF 50M venture capital fund aimed at supporting the development of neuroenhancement technologies.

We're biomedical researchers investing in a new generation of translational founders.

Investing in transformational technologies that elevate mental health and wellness.

Palo Santo’s diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solution…